Comparison of PREVENT with the pooled cohort equation for estimating atherosclerotic cardiovascular disease risk among patients with rheumatoid arthritis
Among a cohort of RA patients, PREVENT and PCE underestimated 10-year ASCVD risk compared to observed ASCVD events, with overall lower risk estimates in PREVENT compared to PCE. Adoption of PREVENT may lead to less aggressive primary CV prevention in RA.
Authors
- Ilana M. Usiskin (ORCID: https://orcid.org/0000-0001-5527-2597)
- Katherine P. Liao (ORCID: https://orcid.org/0000-0002-4797-3200)
- Michael E. Weinblatt (ORCID: https://orcid.org/0000-0001-5215-5512)
- Jorge Plutzky (ORCID: https://orcid.org/0000-0002-7194-9876)
- Ying Qi (ORCID: https://orcid.org/0000-0003-4191-4530)
- Brittany Weber (ORCID: https://orcid.org/0000-0002-0177-2091)
- Mary Jeffway
- Katherine Zhong
- Nancy Shadick
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
Publication Details
- Journal
- American Journal of Preventive Cardiology
- Published
- 2025-10-26
- DOI
- https://doi.org/10.1016/j.ajpc.2025.101338
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67